logo

For the Inventor, By the Inventor

Bengaluru, India

Karthika Nair

This inventor holds 7 USPTO granted patents, plus 3 CIPO patents and 5 EPO patents. Top assignee: Zumutor Biologics Inc.. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karthika Nair. Retrieved from https://idiyas.com/inventor/karthika-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0


 

Average Co-Inventor Count = 26.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Karnataka Bangalore, IN (2022)
  • Bengaluru, IN (2018 - 2023)
  • Karnataka, IN (2023)

Company Filing History:

goldMedal7 out of 9 
 
Zumutor Biologics Inc.
 patents

Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 11549119 - Vectors for cloning and expression of proteins, methods and applications thereof (2023-01-10),
2. 11548937 - DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof (2023-01-10),
3. 11384354 - Method of generating an antibody naïve library, said library and application(s) thereof (2022-07-12),
4. 11267899 - Afucosylated protein, cell expressing said protein and associated methods (2022-03-08),
5. 11230706 - Method of generating a synthetic antibody library, said library and application(s) thereof (2022-01-25),
6. 10752674 - DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof (2020-08-25),
7. 10077434 - Non-fucosylated protein and methods thereof (2018-09-18),

Title: Karthika Nair: Innovator in Biologics

Introduction

Karthika Nair is a prominent inventor based in Bengaluru, India. She has made significant contributions to the field of biologics, particularly in the development of innovative methods and technologies. With a total of 7 patents to her name, Karthika is recognized for her groundbreaking work in genetic engineering and therapeutic development.

Latest Patents

Karthika's latest patents include advancements in the CRISPR system and the production of modified proteins. One of her notable patents focuses on the DNA-binding domain of the CRISPR system, which relates to a method of obtaining cells with modified fucosylation pathways. This innovation leads to the production of partially fucosylated and non-fucosylated protein products, specifically antibodies. The method employs CRISPR technology to target the Fut8 gene and GMD gene, which are crucial for developing therapeutics and biomarkers for disease diagnosis and prognosis.

Another significant patent involves vectors for cloning and expressing genetic material, including antibody genes. This patent describes methods for generating vectors that express antibody genes in various formats, utilizing phage display technology for cloning and screening potential antibody genes. The vectors designed by Karthika offer numerous advantages, including efficient transfer of clonal populations, which enhances library preparation and identification of lead molecules against antigens.

Career Highlights

Karthika Nair is currently associated with Zumutor Biologics Inc., where she continues to push the boundaries of innovation in the field of biologics. Her work has garnered attention for its potential applications in therapeutic development and disease management.

Collaborations

Karthika collaborates with talented individuals in her field, including Sunit Maity and Bhargav Prasad. These collaborations enhance her research and contribute to the advancement of their shared goals in biotechnology.

Conclusion

Karthika Nair stands out as an influential inventor in the realm of biologics, with her innovative patents paving the way for future advancements in therapeutic development. Her contributions are vital to the ongoing evolution of genetic engineering and its applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…